Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
April 30, 2026
April 30, 2026
BALTIMORE, Maryland, April 30 -- The University of Maryland Medical Center issued the following news release:
* * *
Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
A 41-year-old Silver Spring woman who has endured debilitating pain crises and frequent hospitalizations throughout much of her life as the result of sickle cell disease has been treated at the University of Maryland Medical Cen . . .
* * *
Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
A 41-year-old Silver Spring woman who has endured debilitating pain crises and frequent hospitalizations throughout much of her life as the result of sickle cell disease has been treated at the University of Maryland Medical Cen . . .